Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-05-25
1997-02-11
Chang, Ceila
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514320, 514324, 514383, 514359, 514397, 514402, 546196, 546202, 548254, 548255, 5482622, 5483114, A61K 3141, C07D40906
Patent
active
056021631
ABSTRACT:
A class of substituted imidazole, triazole and tetrazole derivatives are selective agonists of 5-HT.sub.1 -like receptors and are therefore useful in the treatment of clinical conditions, in particular migraine and associated disorders, for which a selective agonist of these receptors is indicated.
REFERENCES:
patent: 3475437 (1969-10-01), Landgraf et al.
patent: 3644403 (1972-02-01), Rodriquez et al.
patent: 3801594 (1974-04-01), Poletto et al.
patent: 4138570 (1979-02-01), Psaar
patent: 4453001 (1984-06-01), Brand et al.
patent: 4618617 (1986-10-01), Yamamato
patent: 4672067 (1987-06-01), Coates
patent: 4692531 (1987-09-01), Algieri et al.
patent: 4839377 (1989-06-01), Bays et al.
patent: 4851406 (1989-07-01), Mertens et al.
patent: 4870085 (1989-09-01), Glaser et al.
patent: 4881967 (1989-11-01), Semple
patent: 5037845 (1991-08-01), Oxford
patent: 5225431 (1993-07-01), Robertson
patent: 5436246 (1995-07-01), Bernotas
patent: 5492919 (1996-02-01), Sanger
A. Doenicke, et al. The Lancet, 1988, 1, 1309-11.
Design of Prodrugs, ed. H. Bundgaard, Elsevier, 1985.
Journal of Medicinal Chemistry, vol. 30, No. 1 Jan. 1987 Washington, U.S.R.A. Glenn, `Central Serotonin Receptors as Targets for Drug Research`.
Protective Groups In Organic Chemistry, ed. Plenum Press, 1973.
T. W. Greene, Protective Groups In Organic Synthesis, John Wiley & Sons, 1981.
J. Neurosci, 7, 894 (1987).
Arch. Pharm., 342, 111 (1990).
J. Org. Chem., vol. 47, p. 536-544 (1982) by Jose Elguero, et al., entitled Synthesis and Physicochemical Properties of 1, 2, b-Thiadiazine 1, 1-Dioxides.
Chem. Ber. vol. 111, p. 1915-1971 (1978) by M. Preiss, entitled 1, 2, 5-Thiadiazolidin-1, 1-dioxidund Homologe.
Indian J. of Chem., vol. 21B, pp 941-944 (10/82) by V. P. Arya, et al., entitled Nitroimidazoles: Part V-1[1-Methyl-5-nitroimidazol-2-yl]-1, 2-4-triazolidin-3, 5-diones & Analogues.
Moltzen et al. "Fused heterocyclobenzo 5HT1A receptor antagonists and agonists" CA 122:290887 (1994).
Baker Raymond
Matassa Victor G.
Street Leslie J.
Chang Ceila
Merck Sharp & Dohme Ltd.
North Robert J.
Winokur Melvin
LandOfFree
Imidazole, triazole and tetrazole derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Imidazole, triazole and tetrazole derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazole, triazole and tetrazole derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-342591